The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2016

Filed:

Aug. 21, 2009
Applicants:

Jan Kitajewski, Ridgewood, NJ (US);

Carrie Shawber, Washington Township, NJ (US);

Inventors:

Jan Kitajewski, Ridgewood, NJ (US);

Carrie Shawber, Washington Township, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); C07K 14/71 (2006.01); C07K 14/715 (2006.01); C07K 16/46 (2006.01); C07K 19/00 (2006.01); C07K 14/485 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/485 (2013.01); C07K 14/705 (2013.01); A61K 38/177 (2013.01); A61K 38/179 (2013.01); A61K 38/1793 (2013.01); A61K 39/395 (2013.01); A61K 2039/505 (2013.01); C07K 14/71 (2013.01); C07K 14/715 (2013.01); C07K 16/46 (2013.01); C07K 2319/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/30 (2013.01);
Abstract

This invention provides a fusion protein comprising a signal peptide, EGF repeats 1-X of the extracellular domain of human Notch3 receptor protein wherein X is any integer from 12 to 34, and an Fc portion of an antibody bound thereto. This invention also provides a method for treating a subject having a tumor, a method for inhibiting angiogenesis in a subject, a method for treating a subject having ovarian cancer, and a method for treating a subject having a metabolic disorder, comprising administering to the subject an amount of the above fusion protein effective to treat the subject. This invention further provides uses of the above fusion protein for the preparation of a pharmaceutical composition for the treatment of a subject having a tumor, for inhibiting angiogenesis in a subject, for treating a subject having ovarian cancer, and for treating a subject having a metabolic disorder.


Find Patent Forward Citations

Loading…